Aleafia Labs Partners on Cannabinoid Pharmacogenetics Study Study with G420, US-Based AKESOgen aimed at producing genetic tools for improved medical cannabis therapy TORONTO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aleafia Labs, a division of Aleafia Health Inc.... read more → October 30, 2018 Ryan T.
